Quarterly Report • Jun 21, 2017
Quarterly Report
Open in ViewerOpens in native device viewer
Washington, D.C. 20549
For the month of June 2017 Commission File Number: 001-35284
(Translation of registrant's name into English)
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________
THE IFRS FINANCIAL RESULTS INCLUDED IN EXHIBIT 99.1 OF THIS FORM 6-K ARE HEREBY INCORPORATED BY REFERENCE INTO THE REGISTRANT'S REGISTRATION STATEMENTS ON FORM F-3 (NOS. 333-199696 AND 333-144171) AND FORM S-8 (NOS. 333-187533, 333-102288 AND 333-92491), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
This Report on Form 6-K of Ellomay Capital Ltd. consists of the following document, which is attached hereto and incorporated by reference herein:
Exhibit 99.1. Press Release: "Ellomay Capital Reports Results for the Three Months Ended March 31, 2017," dated June 21, 2017.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Ellomay Capital Ltd.
By: /s/ Ran Fridrich Ran Fridrich Chief Executive Officer and Director
Dated: June 21, 2017

Tel-Aviv, Israel, June 21, 2017 – Ellomay Capital Ltd. (NYSE MKT; TASE: ELLO) ("Ellomay" or the "Company") an emerging operator in the renewable energy and energy infrastructure sector, today reported its unaudited financial results for the three month period ended March 31, 2017.
Revenues were approximately \$2.7 million (approximately €2.5 million) for the three months ended March 31, 2017, compared to approximately \$2.5 million (approximately €2.3 million) for the three months ended March 31, 2016. The increase in revenues is mainly due to higher levels of radiation and relatively higher electricity spot prices in Italy as a result of the replacement of the electricity broker.
Operating expenses were approximately \$0.5 million (approximately €0.5 million) for the three months ended March 31, 2017, compared to approximately \$0.6 million (approximately €0.5 million) for the three months ended March 31, 2016. The decrease in operating expenses is mainly attributable to the reduction of municipal taxes in Italy as a result of legislation adopted during the second quarter of 2016. Depreciation expenses were approximately \$1.2 million (approximately €1.1 million) for the three month periods ended March 31, 2017 and 2016.
General and administrative expenses were approximately \$1.4 million for the three months ended March 31, 2017, compared to approximately \$1.1 million for the three months ended March 31, 2016. During the first quarter of 2017 the Company invested approximately \$0.6 million in the Pumped Storage Project in the Manara Cliff in Israel, compared to an expenditure of approximately \$0.4 million in the first quarter of 2016, which is recorded in the general and administrative expenses. The increase in general and administrative expenses was primarily related to these expenses, in addition to increased consulting expenses in connection with the development of Waste to Energy projects in the Netherlands.
Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately \$0.8 million for the three month periods ended March 31, 2017 and 2016.
Financing expenses, net were approximately \$2.1 million for the three months ended March 31, 2017, compared to approximately \$2.7 million for the three months ended March 31, 2016. The change in financing expenses was mainly due to approximately \$1.7 million expenses in connection with derivatives, partially offset by the change resulting from exchange rate differences in the amount of approximately \$1.2 million.
Taxes on income were approximately \$0.1 million for the three months ended March 31, 2017, compared to tax benefit of approximately \$0.1 million for the three months ended March 31, 2016.
Net loss was approximately \$1.8 million for the three months ended March 31, 2017, compared to net loss of approximately \$2.1 million for the three months ended March 31, 2016.
Total other comprehensive income was approximately \$2 million for the three months ended March 31, 2017, compared to approximately \$3.3 million for the three months ended March 31, 2016. The change was mainly due to presentation currency translation adjustments as a result of fluctuations in the Euro/USD exchange rates. Such income is a result of the revaluation in the Euro against the U.S. Dollar of approximately 2% for the three months ended March 31, 2017, compared to approximately 5% for the three months ended March 31, 2016.
Total comprehensive income was approximately \$0.2 million for the three months ended March 31, 2017, compared to total comprehensive income of approximately \$1.2 million for the three months ended March 31, 2016.
EBITDA was approximately \$1.6 million for the three months ended March 31, 2017, compared to approximately \$1.7 million for the three months ended March 31, 2016.
Net cash provided by operating activities was approximately \$1.6 million for the three months ended March 31, 2017, compared to approximately \$0.03 million for the three months ended March 31, 2016. The increase in net cash from operating activities is mainly attributable to higher collection of revenues during the three months ended March 31, 2017, as October 2016 revenues from electricity produced in Italy were collected in January 2017 while October 2015 revenues were collected in December 2015.
On March 14, 2017, the Company issued Series B Nonconvertible Debentures due June 30, 2024 in a public offering in Israel in the aggregate principal amount of NIS 123,232,000 (approximately \$33.7 million based on the U.S. Dollar/NIS exchange rate at that time). The Series B Debentures bear fixed interest at the rate of 3.44% per year and are not linked to the Israeli CPI or otherwise. The gross proceeds of the offering were NIS 123,232,000 and the net proceeds of the offering, net of related expenses such as consultancy fee and commissions (partially paid in 2016), were approximately NIS 121.4 million (approximately \$33.6 million).
In June 2017, the financial closing of the project to construct an anaerobic digestion plan in Oude Tonge, The Netherlands (the "Oude Tonge Project"), occurred, whereby Coöperatieve Rabobank U.A. agreed to provide the following financing tranches: (i) two loans with principal amounts of Euro 3.15 million and Euro 1.7 million, each with a fixed annual interest rate of 3.1% for the first five years, for a period of 12.25 years, repayable in equal monthly installments commencing three months following the connection of the Goor Project's facility to the grid and (ii) an on-call credit facility of Euro 100,000 with variable interest. The Oude Tonge Project executed an engineering, procurement and construction agreement with an affiliate of the entity that holds the remaining 49% of the project company (Ludan Energy Overseas B.V. ("Ludan")) and is expected to enter into an operation and maintenance agreement with an affiliate of Ludan, both based on terms already agreed to by us and Ludan. It is estimated that the duration of the construction of the Oude Tonge Project shall be approximately one year and the expected overall capital expenditure in connection with the Oude Tonge Project are approximately Euro 8.5 million (approximately \$9.3 million).
In May 2017, the Israeli High Court dismissed the petition filed by Ellomay Pumped Storage (2014) Ltd. ("Ellomay PS") in March 2017 against the Israeli Minister of National Infrastructures, Energy and Water Resources, the Israeli Electricity Authority and the owner of the Kochav Hayarden pumped storage project ("KH"). In June 2017, the Court accepted an application filed by KH requesting that the Court maintain the NIS 2 million guarantee that was provided by Ellomay PS, due to costs and alleged damages caused to KH and the costs caused of the governmental authorities and ruled that the guarantee will be maintained by the Court for a period of three months pending a filing of a claim for damages by KH. According to the ruling, in case a claim will not filed by KH within the said three months, the guarantee will be returned to Ellomay PS. The dismissal of the petition does not change the Company's intention to continue promoting the Manara Project and the Company is examining various methods of action in that respect.
As of June 1, 2017, the Company held approximately \$42 million in cash and cash equivalents, approximately \$8 in marketable securities and approximately \$2.1 million in short-term and longterm restricted cash.
Ran Fridrich, CEO and a board member of Ellomay commented: "The quarterly results reflect an increase of approximately 40% in gross profit. The increase in general and administrative expenses is due to costs associated with an increase in the number of projects under advanced development (Talasol – 300MW PV project in Spain, Oude Tonge Waste to Energy project in the Netherlands, Manara pumped Storage project)Financing expenses decreased and include significant exchange rate differentials, in the amount of \$1.4, which do not constitute a cash flow expense. Cash flow from operating activities for the quarter was strong, at \$1.6 million. The Company continues to develop future projects in Israel and abroad, while increasing its portfolio of yielding assets, which are expected to increase the Company's revenues and profits."
As of March 31, 2017, the Company's Net Financial Debt (as such term is defined in the Deeds of Trust of the Company's Debentures) was approximately \$11.7 million (consisting of approximately \$26.4 million of short-term and long-term debt from banks and other interest bearing financial obligations and approximately \$71.1 million in connection with the Series A Debentures issuances (in January and September 2014) and the Series B Debentures issuance (in March 2017), net of approximately \$62 million of cash and cash equivalents and marketable securities and net of approximately \$23.8 million of project finance and related hedging transactions of the Company's subsidiaries).
EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's historical financial performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures, and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measures presented by other companies. The Company's EBITDA may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. A reconciliation between results on an IFRS and non-IFRS basis is provided in the last table of this press release.
Ellomay is an Israeli based company whose shares are registered with the NYSE MKT and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the energy and infrastructure sectors worldwide. Ellomay (formerly Nur Macroprinters Ltd.) previously was a supplier of wide format and super-wide format digital printing systems and related products worldwide, and sold this business to Hewlett-Packard Company during 2008 for more than \$100 million.
To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:
75% of Chashgal Elyon Ltd., Agira Sheuva Electra, L.P. and Ellomay Pumped Storage (2014) Ltd., all of which are involved in a project to construct a 340 MW pumped storage hydro power plant in the Manara Cliff, Israel;
51% of Groen Gas Goor B.V. and of Groen Gas Oude-Tonge B.V., project companies developing anaerobic digestion plants with a green gas production capacity of approximately 375 Nm3/h, in Goor, the Netherlands and 475 Nm3/h, in Oude Tonge, the Netherlands, respectively.
Ellomay Capital is controlled by Mr. Shlomo Nehama, Mr. Hemi Raphael and Mr. Ran Fridrich. Mr. Nehama is one of Israel's prominent businessmen and the former Chairman of Israel's leading bank, Bank Hapohalim, and Messrs. Raphael and Fridrich both have vast experience in financial and industrial businesses. These controlling shareholders, along with Ellomay's dedicated professional management, accumulated extensive experience in recognizing suitable business opportunities worldwide. Ellomay believes the expertise of Ellomay's controlling shareholders and management enables the Company to access the capital markets, as well as assemble global institutional investors and other potential partners. As a result, we believe Ellomay is capable of considering significant and complex transactions, beyond its immediate financial resources.
This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by our forward-looking statements including changes in regulation, seasonality of the PV business and market conditions. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: Kalia Weintraub CFO Tel: +972 (3) 797-1111 Email: [email protected] Condensed Consolidated Interim Statements of Financial Position
| Unaudited Audited US\$ in thousands Assets Current assets Cash and cash equivalents 58,897 Marketable securities 3,082 Restricted cash 16 Trade and other receivables 9,444 71,439 34,641 Non-current assets Investment in equity accounted investee 33,016 30,788 Advances on account of investments 944 905 Financial assets 1,413 1,330 Fixed assets 78,609 77,066 Restricted cash and deposits 1,922 5,399 Deferred tax 2,670 2,614 Long term receivables 3,491 3,431 122,065 121,533 Total assets 193,504 156,174 Liabilities and Equity Current liabilities Current maturities of long term loans 1,181 1,150 Debentures 5,380 4,989 Trade payables 2,058 1,684 Other payables 3,769 3,279 12,388 11,102 Non-current liabilities Finance lease obligations 4,210 4,228 Long-term loans 20,277 17,837 Debentures 65,720 30,548 Deferred tax 1,008 925 Other long-term liabilities 911 2,764 92,126 56,302 Total liabilities 104,514 67,404 Equity Share capital 26,597 26,597 Share premium 77,727 77,727 Treasury shares (1,999) (1,985) Reserves (14,998) (17,024) Retained earnings 2,583 4,191 Total equity attributed to shareholders of the Company 89,910 89,506 Non-Controlling Interest (920) Total equity 88,990 88,770 Total liabilities and equity 193,504 156,174 |
March 31, 2017 |
December 31, 2016 |
|
|---|---|---|---|
| 23,650 | |||
| 1,023 | |||
| 16 | |||
| 9,952 | |||
| (736) | |||
| For the three months ended March 31, 2017 |
For the three months ended March 31, 2016 |
For the year ended December 31, 2016 Audited |
||
|---|---|---|---|---|
| Unaudited | Unaudited | |||
| US\$ thousands (except per share amounts) | ||||
| Revenues | 2,688 | 2,546 | 12,872 | |
| Operating expenses | (537) | (608) | (2,305) | |
| Depreciation expenses | (1,169) | (1,221) | (4,884) | |
| Gross profit | 982 | 717 | 5,683 | |
| General and administrative expenses | *(1,361) | *(1,084) | (4,679) | |
| Share of profits of equity accounted investee | 835 | 845 | 1,505 | |
| Other income, net | 5 | 44 | 99 | |
| Operating Profit | 461 | 522 | 2,608 | |
| Financing income | 93 | 54 | 290 | |
| Financing income (expenses) in connection with derivatives, net | (5) | (1,743) | 704 | |
| Financing expenses | (2,216) | (993) | (4,050) | |
| Financing expenses, net | (2,128) | (2,682) | (3,056) | |
| Loss before taxes on income | (1,667) | (2,160) | (448) | |
| Tax benefit (taxes on income) | 125 | 53 | (625) | |
| Net loss for the period | (1,792) | (2,107) | (1,073) | |
| Loss attributable to: | ||||
| Owners of the Company | (1,608) | (1,988) | (605) | |
| Non-controlling interests | (184) | (119) | (468) | |
| Net loss for the period | (1,792) | (2,107) | (1,073) | |
| Other comprehensive income (loss) | ||||
| Items that are or may be reclassified to profit or loss: | ||||
| Foreign currency translation adjustments | (1,111) | (671) | (267) | |
| Items that would not be reclassified to profit or loss: | ||||
| Presentation currency translation adjustments | 3,137 | 3,971 | (1,542) | |
| Total other comprehensive income (loss) | 2,026 | 3,300 | (1,809) | |
| Total comprehensive income (loss) | 234 | 1,193 | (2,882) | |
| Basic net loss per share | (0.15) | (0.19) | (0.06) | |
| Diluted net loss per share | (0.15) | (0.19) | (0.06) |
* Expenses in the amount of approximately \$0.6 million in connection with "Manara PSP" were recorded in the general and administrative expenses for the three months ended March 31, 2017, compared to approximately \$0.4 million for the three months ended March 31, 2016.
Condensed Consolidated Interim Statements of Changes in Equity
| Attributable to owners of the Company | Non controlling interests |
Total Equity |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Retained earnings |
Treasury shares |
Translation reserve from foreign operations Unaudited |
Presentation currency translation reserve |
Total | |||
| For the three months ended March 31, 2017 |
US\$ in thousands | ||||||||
| Balance as at January 1, 2017 Loss for the period Other comprehensive income Total comprehensive income |
26,597 - - - |
77,727 - - - |
4,191 (1,608) - (1,608) |
(1,985) - - - |
547 - (1,111) (1,111) |
(17,571) - 3,137 3,137 |
89,506 (1,608) 2,026 418 |
(736) (184) - (184) |
88,770 (1,792) 2,026 234 |
| Own shares acquired Balance as at March 31, 2017 |
- 26,597 |
- 77,727 |
- 2,583 |
(14) (1,999) |
- (564) |
- (14,434) |
(14) 89,910 |
- (920) Non controlling |
(14) 88,990 Total |
| Attributable to owners of the Company | interests | Equity | |||||||
| Share capital |
Share premium |
Retained earnings |
Treasury shares |
Translation reserve from foreign operations Unaudited |
Presentation currency translation reserve |
Total | |||
| For the three months ended | US\$ in thousands | ||||||||
| March 31, 2016 | |||||||||
| Balance as at January 1, 2016 |
26,597 | 77,723 | 7,200 | (1,972) | 814 | (16,029) | 94,333 | (268) | 94,065 |
| Loss for the period Other comprehensive income |
- - |
- - |
(1,988) - |
- - |
- (671) |
- 3,971 |
(1,988) 3,300 |
(119) - |
(2,107) 3,300 |
| Total comprehensive income Own shares acquired Dividend distribution |
- - - |
- - - |
(1,988) - (2,403) |
- (8) - |
(671) - - |
3,971 - - |
1,312 (8) (2,403) |
(119) - - |
1,193 (8) (2,403) |
| Balance as at March 31, 2016 |
26,597 | 77,723 | 2,809 | (1,980) | 143 | (12,058) | 93,234 | (387) | 92,847 |
Condensed Consolidated Interim Statements of Changes in Equity (cont'd)
| Attributable to owners of the Company | Non controlling interests |
Total Equity |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Retained earnings (accumulated Deficit) |
Treasury shares |
Translation reserve from foreign operations Audited |
Presentation currency translation reserve |
Total | |||
| For the year ended | US\$ in thousands | ||||||||
| December 31, 2016 | |||||||||
| Balance as at | |||||||||
| January 1, 2016 | 26,597 | 77,723 | 7,200 | (1,972) | 814 | (16,029) | 94,333 | (268) | 94,065 |
| Loss for the year | - | - | (605) | - | - | - | (605) | (468) | (1,073) |
| Other comprehensive loss | - | - | - | - | (267) | (1,542) | (1,809) | - | (1,809) |
| Total comprehensive income | - | - | (605) | - | (267) | (1,542) | (2,414) | (468) | (2,882) |
| Transactions with owners of the Company, recognized directly in |
|||||||||
| equity: | |||||||||
| Dividends to owners | - | - | (2,404) | - | - | - | (2,404) | - | (2,404) |
| Own shares acquired | - | - | - | (13) | - | - | (13) | - | (13) |
| Share-based payments | - | 4 | - | - | - | - | 4 | - | 4 |
| Balance as at December 31, 2016 |
26,597 | 77,727 | 4,191 | (1,985) | 547 | (17,571) | 89,506 | (736) | 88,770 |
Condensed Consolidated Interim Statements of Cash Flows
| For the three months ended March 31, 2017 |
For the three months ended March 31, 2016 |
For the year ended December 31, 2016 |
||
|---|---|---|---|---|
| Unaudited | Unaudited | Audited | ||
| US\$ in thousands | ||||
| Cash flows from operating activities | ||||
| Income (loss) for the period | (1,792) | (2,107) | (1,073) | |
| Adjustments for: | ||||
| Financing expenses, net | 2,128 | 2,682 | 3,056 | |
| Depreciation | 1,169 | 1,221 | 4,884 | |
| Share-based payment transactions | - | - | 4 | |
| Share of profits of equity accounted investees | (835) | (845) | (1,505) | |
| Payment of interest on loan from an equity accounted investee | - | - | 5,134 | |
| Change in trade receivables and other receivables | (34) | 51 | (1,798) | |
| Change in other assets | (75) | (549) | (805) | |
| Change in accrued severance pay, net | 1 | - | (18) | |
| Change in trade payables | 349 | 265 | 850 | |
| Change in other payables | 664 | (463) | 1,955 | |
| Income tax expense (tax benefit) | 125 | (53) | 625 | |
| Income taxes paid | - | - | (54) | |
| Interest received | 93 | 37 | 251 | |
| Interest paid | (160) | (207) | (3,300) | |
| Net cash provided by operating activities | 1,633 | 32 | 8,206 | |
| Cash flows from investing activities | ||||
| Acquisition of fixed assets | (1,458) | - | (5,388) | |
| Investment in equity accounted investee | ||||
| - | (36) | (803) | ||
| Settlement of SWAP contract | (2,180) | - | - | |
| Advances on account of investments | (39) | - | (905) | |
| Repayment of loan from an equity accounted investee | - | - | 2,638 | |
| Decrease (increase) in restricted cash, net | 3,501 | - | (31) | |
| Acquisition of marketable securities | (2,085) | - | (1,022) | |
| Proceeds from marketable securities | - | - | 6,511 | |
| Net cash provided by (used in) investing activities | (2,261) | (36) | 1,000 | |
| Cash flows from financing activities | ||||
| Dividends paid | - | (2,404) | ||
| Repayment of long-term loans and finance lease obligations | (88) | (88) | (1,169) | |
| Repayment of Debentures | - | - | (5,210) | |
| Proceeds from long-term loans | 2,081 | - | 6,001 | |
| Repurchase of own shares | (14) | (8) | (13) | |
| Proceeds from issuance of debentures, net | 33,707 | - | - | |
| Net cash provided by (used in) financing activities | 35,686 | (96) | (2,795) | |
| Effect of exchange rate fluctuations on cash and cash equivalents | 189 | 809 | (1,478) | |
| Increase in cash and cash equivalents | 35,247 | 709 | 4,933 | |
| Cash and cash equivalents at the beginning of the period | 23,650 | 18,717 | 18,717 | |
| Cash and cash equivalents at the end of the period | 58,897 | |||
| 19,426 | 23,650 |
| For the three months ended March 31, 2017 |
For the three months ended March 31, 2016 Unaudited |
For the year ended December 31, 2016 |
|
|---|---|---|---|
| US\$ in thousands | |||
| Net loss for the period | (1,792) | (2,107) | (1,073) |
| Financing expenses, net | 2,128 | 2,682 | 3,056 |
| Taxes on income (tax benefit) | 125 | (53) | 625 |
| Depreciation and amortization | 1,169 | 1,221 | 4,884 |
| EBITDA | 1,630 | 1,743 | 7,492 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.